
Work Here?
Phreesia provides a cloud-based patient intake platform for medical practices. It automates front-office tasks such as appointment scheduling, insurance verification, and payment processing, helping providers reduce paperwork and spend more time with patients. The platform also supports real-time patient surveys, clinical and behavioral health screenings, and data analytics. It integrates with leading EMR and Practice Management systems so patient data stays up to date across systems. Phreesia runs on a SaaS model with subscription fees, optional premium features, and transaction-based payment processing fees, plus charges for value-added services. Compared with competitors, it emphasizes seamless EMR/PM integration, automated end-to-end intake, and actionable insights from analytics to boost patient engagement and operational efficiency. The goal is to streamline administrative workflows, shorten wait times, and improve the overall patient experience in healthcare settings.
Industries
Data & Analytics
Enterprise Software
Healthcare
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Wilmington, Delaware
Founded
2005
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$461.9M
Above
Industry Average
Funded Over
10 Rounds
Remote Work Options
Home Office Stipend
Phone/Internet Stipend
Wellness Program
Flexible Work Hours
Paid Holidays
Paid Vacation
Parental Leave
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
Pet Insurance
Professional Development Budget
Company Equity
Phreesia alternatives in Canada. Canadian buyers face a smaller field, because most US patient engagement vendors do not integrate with Canadian primary care EMRs. * Ocean (OceanMD): owned by WELL Health Technologies, and now branded "A WELLSTAR Company". Ocean calls itself "Canada's digital gateway for healthcare" and splits its product into a Patient Engagement Suite (booking, messaging, reminders, check-in kiosks, self-serve forms) and the Ocean Provider Network (eReferrals, eConsults, eSubmissions, eOrders). It reports 50,000+ users and 170,000+ eReferrals a month, and names four integrated EMRs: PS-Suite, Med Access, Accuro and Oscar Pro. Consider it first if your pain is referrals. * Mikata Health: Canadian, bilingual English/French, and now positioned as "the all-in-one AI clinic assistant". Its named products go well past reminders: AI clinical documentation, referrals and forms, coding and billing, patient triage, booking, intake, follow-up, secure messaging, campaigns and check-in. It says it is "integrated with the biggest EMRs in Canada" but does not name them on its site, and it does not publish prices, so ask for both. * Pomelo Health: Canadian (formerly Chronometriq, founded 2012), with online booking, reminders, secure messaging, mobile check-in, e-forms, telemedicine, broadcast messaging and a queue-management system for urgent care. Its distinctive track record is mass-booking at scale for pharmacy banners and provincial health authorities: vaccination and testing campaigns rather than day-to-day family practice. Note that pomelohealth.com is the Canadian company; Pomelo Care is an unrelated US business. Cortico's Canadian position is the EMR list: Oscar 19 and WELL OscarPro, Juno and Accuro are all rated COMPLETE or better, and Flow EMR and OpenOSP are COMPLETE+. Phreesia pricing: what is actually public. Searchers looking for "Phreesia pricing" usually find the same thing we did. Phreesia has a pricing page, but it carries no numbers. It says pricing "is customized to your organization based on factors like your size, workflows and the products you use," and points you at a demo to get a tailored quote. That was still true when Cortico Health Technologies Inc. checked on 28 July 2026. Reported costs vary widely by practice size and module mix, and Cortico Health Technologies Inc. is not going to quote a number Cortico Health Technologies Inc. cannot source. What Cortico Health Technologies Inc. can do is work backwards from Phreesia's own public filings. In fiscal 2026 Phreesia booked $219.5 million of subscription and related services revenue across an average of 4,514 healthcare services clients. That is about $48,600 per client per year, or roughly $4,050 a month, before the payment-processing and network-solutions revenue that makes up the other $261 million. Read that as an order of magnitude, not a quote. Phreesia's client base skews to large multi-provider organizations, so a per-client average is not a per-provider price, and your own number could sit well above or below it. The point is the contrast: you can see Cortico's per-provider price on its website before you talk to anyone. That opacity is a real evaluation cost. You cannot compare two vendors on price when only one of them will tell you the price before a discovery call. For contrast, Cortico's is on the page: $86, $119 or $199 per provider per month, $99 minimum, add-ons listed individually. Most years prices do not change; when they do, customers get a year's notice and have historically been grandfathered, and a rate lock is available on request. How to choose. * Start with your EMR. Ask each vendor to name your EMR and describe exactly what writes back to the chart. Vague answers here predict painful implementations. * Separate intake from automation. Digital forms are table stakes. Ask what happens to faxes, follow-ups and recalls, because that is where the staff hours actually go. * Get a price before the demo. If a vendor will not indicate a range, budget extra time for procurement. * Count the tools you would retire. A platform that replaces booking, reminders, forms, messaging, video and payments is a different calculation than a point solution. Want to see it against your own schedule and EMR? Book a demo.
Phreesia and March of Dimes partner to help strengthen physician-patient conversations and improve the health of moms and babies. * Published - July 23, 2026 This new collaboration reaches patients and their providers with information on widespread, preventable maternal health conditions. ALL-REMOTE COMPANY/WILMINGTON, Del. - JULY 23, 2026 - Phreesia, a leader in patient intake, outreach and activation that enables one in six patient visits across the U.S., and March of Dimes, the nation's leading nonprofit fighting for the health of all moms and babies, announced a partnership designed to enhance critical physician-patient conversations during prenatal and postpartum appointments, ultimately intended to improve the health of mothers and their babies across the United States. Through this collaboration, the organizations will reach new parents and caregivers of infants and their healthcare providers, with timely, evidence-based education just ahead of relevant appointments. The campaign brings March of Dimes' educational content to clinically relevant patients, along with complementary resources for providers who have upcoming appointments with pregnant patients and caregivers of infants. With the goal of improving maternal and infant health outcomes, Phreesia and March of Dimes aim to raise awareness on three important issues: preeclampsia, recognition and resources for postpartum depression, and practices to support safe sleep for infants. "Every mom deserves access to trusted, timely information that helps them have meaningful conversations with their provider and make informed decisions throughout their pregnancy, birth, and postpartum," said Kelly Ernst, Chief Impact Officer, March of Dimes. "However, it can be challenging to know what questions to ask and when during the pregnancy journey. We're proud to partner with Phreesia to share evidence-based resources ahead of key appointments to strengthen those conversations, helping improve the health of moms and babies." What sets this campaign apart is that it closes the loop between patients and providers by pairing patient education with provider-facing resources just before they meet at medical appointments, so both are ready to have important conversations. By reaching both providers and patients, the campaign is designed to amplify common messages across both audiences for better shared decision-making and improved outcomes. "We are delighted to bring March of Dimes' expertise on the health of new mothers and babies to the Phreesia network," said David Linetsky, President, Phreesia Network Solutions. "By placing relevant educational resources directly in the hands of patients and providers, this collaboration is an opportunity to create a positive, tangible impact on the maternal health crisis in the U.S." About phreesia. Phreesia is the trusted leader in patient activation, giving healthcare providers, life sciences companies and other organizations tools to help patients take a more active role in their care. Founded in 2005, Phreesia enabled more than 180 million patient visits in 2025 - 1 in 6 visits across the U.S. This scale allows Phreesia to make meaningful impact across the healthcare ecosystem. Offering patient-driven digital solutions for intake, outreach, education and more, Phreesia enhances the patient experience, drives operational efficiency and improves healthcare outcomes. To learn more, visit phreesia.com. About March of Dimes. March of Dimes leads the fight for the health of all moms and babies. Phreesia support research, education, and advocacy, and provide programs and services so that every family can have the best possible start. Since 1938, Phreesia has built a successful legacy to support every pregnant person and every family. Visit marchofdimes.org or nacersano.org for more information. Find Phreesia on Facebook and follow Phreesia with #marchofdimes and @marchofdimes. Media contact The best-performing practices run on Phreesia. See what a smarter front office can do for your practice.
Phreesia has raised $120 million in Series C funding led by Ribbit Capital, valuing the healthcare technology company at $1.45 billion. Sequoia and Kleiner Perkins participated alongside new investor Emerson Collective. The company reported strong earnings quality, with free cash flow of $63 million significantly exceeding its $9.18 million statutory profit for the year to April 2026. This resulted in a negative accrual ratio of -0.19, indicating solid cash generation. However, unusual items worth $9.7 million reduced reported profits during the period. Founded in 2023, Phreesia has now raised $295 million total across three rounds in 14 months, demonstrating continued investor confidence in the healthcare sector.
Phreesia, a healthcare technology company offering SaaS-based software and payment platforms, was highlighted in Cambiar SMID Fund's Q1 2026 investor letter despite a significant quarterly decline. The stock closed at $9.65 per share on 3 June 2026, down 62.57% over the past 52 weeks, with a market capitalisation of $596.48 million. The company experienced drawdowns due to AI disruption fears and reduced advertising revenue from vaccine providers and GLP-1 companies. However, Phreesia maintained its full-year EBITDA guidance, citing continued client growth and stronger pricing. With over 5,000 providers and 100,000 physicians in its customer base and a strong balance sheet, Cambiar SMID Fund believes the company offers strong upside potential. Phreesia reported $130.9 million in total revenue, up 13% year-over-year.
PHR investors have opportunity to lead Phreesia, Inc. securities fraud lawsuit with the Schall Law Firm. GlobeNewswire | Schall Law Today at 7:37am PDT LOS ANGELES, May 22, 2026 (GLOBE NEWSWIRE) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Phreesia, Inc. ("Phreesia" or "the Company") (NYSE: PHR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between May 8, 2025 and March 30, 2026, inclusive (the "Class Period"), are encouraged to contact the firm before July 13, 2026. Pamplin Media Group also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach Pamplin Media Group through the firm's website at www.schallfirm.com, or by email at [email protected]. The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. According to the Complaint, the Company made false and misleading statements to the market. Phreesia misled investors by claiming to possess a reliable basis for its long-term growth outlook and its confidence in growth projections for fiscal year 2027. The Company claimed its pharmaceutical marketing commitments would act as a growth driver for the Network Solutions segment despite uncertainty that would put its revenue target at risk. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Phreesia, investors suffered damages. The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. The Schall Law Firm This is a paid placement. For further inquiries, please contact GlobeNewswire directly.
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Enterprise Software
Healthcare
Company Size
1,001-5,000
Company Stage
IPO
Headquarters
Wilmington, Delaware
Founded
2005
Find jobs on Simplify and start your career today